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FIGURE 3: Molecular Mechanisms involved in PD pathogenesis
(needs to be adapted from: Althauda&Foltynie, Nat Rev Neurol 2015)
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FIGURE 5
FIGURE 6: please see separate file
FIGURE 7
Dopaminergic drug targets to treat the motor symptoms of PD
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FIGURE 8: Mechanisms underlying L-Dopa Induced dyskinesias
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